DE60231605D1 - Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen - Google Patents

Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen

Info

Publication number
DE60231605D1
DE60231605D1 DE60231605T DE60231605T DE60231605D1 DE 60231605 D1 DE60231605 D1 DE 60231605D1 DE 60231605 T DE60231605 T DE 60231605T DE 60231605 T DE60231605 T DE 60231605T DE 60231605 D1 DE60231605 D1 DE 60231605D1
Authority
DE
Germany
Prior art keywords
weakage
immunomodulator
hiv
virus
human immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60231605T
Other languages
English (en)
Inventor
Mafatlal Bakulesh
Ambalal Indravadan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60231605D1 publication Critical patent/DE60231605D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60231605T 2001-01-17 2002-01-17 Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen Expired - Lifetime DE60231605D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN50MU2001 2001-01-17
PCT/IB2002/000098 WO2002056898A2 (en) 2001-01-17 2002-01-17 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection

Publications (1)

Publication Number Publication Date
DE60231605D1 true DE60231605D1 (de) 2009-04-30

Family

ID=11097205

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60231605T Expired - Lifetime DE60231605D1 (de) 2001-01-17 2002-01-17 Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen

Country Status (9)

Country Link
EP (1) EP1368044B1 (de)
AP (1) AP2001A (de)
AT (1) ATE425759T1 (de)
DE (1) DE60231605D1 (de)
ES (1) ES2324467T3 (de)
GB (1) GB2382529B (de)
PT (1) PT1368044E (de)
WO (1) WO2002056898A2 (de)
ZA (1) ZA200306367B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200800917A1 (ru) * 2005-04-25 2008-12-30 Бакулиш Мафатлал Хамар Адъюванты для вакцин
GB2450580B (en) * 2006-11-23 2010-04-14 Cadila Pharmaceuticals Ltd Poly-TLR antagonist
CN110331081B (zh) * 2019-06-06 2022-09-23 武汉仝干医疗科技股份有限公司 细胞冲洗容器、细胞收集冲洗方法及系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine

Also Published As

Publication number Publication date
GB2382529A (en) 2003-06-04
ZA200306367B (en) 2005-03-07
AP2001A (en) 2009-05-11
WO2002056898A3 (en) 2003-10-16
EP1368044B1 (de) 2009-03-18
GB2382529B (en) 2004-01-28
WO2002056898A2 (en) 2002-07-25
AP2003002847A0 (en) 2003-09-30
ATE425759T1 (de) 2009-04-15
PT1368044E (pt) 2009-06-08
ES2324467T3 (es) 2009-08-07
GB0301354D0 (en) 2003-02-19
EP1368044A2 (de) 2003-12-10

Similar Documents

Publication Publication Date Title
IS7133A (is) Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni
BRPI0411900B8 (pt) compostos e composições farmacêuticas compreendendo os mesmos
HK1077601A1 (zh) 針對人免疫缺陷病毒的遺傳疫苗
DE60215157D1 (de) Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
WO2006110655A3 (en) Compounds, compositions and methods for the treatment of poxvirus infections
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
AU2001268373A1 (en) Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
DK1427444T3 (da) West-nil-vaccine
NO20033882L (no) Vaksine
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
PT1299395E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
GB0329254D0 (en) Treatment of viral infections
NO20033829L (no) Virusdrepende preparater
DE60207811D1 (de) Zusammensetzungen zur entfernung von menschlichem cerumen
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
DE60231605D1 (de) Immunomodulator zur bekämpfung von durch humanen immunschwächevirus (hiv) vermittelte krankheiten/infektionen
DE60032915D1 (de) Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
GB0329958D0 (en) Treatment of viral infections
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
AU2002343146A1 (en) Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
DK1351697T3 (da) Lægemiddel til fremme af regenerationen af væv
EA200700878A1 (ru) Лечение или предупреждение геморрагических вирусных инфекций с помощью иммуномодулирующих соединений
NO20024325D0 (no) Rensede hepatitt C-viruskappeproteiner for diagnostisk og terapeutisk anvendelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803